Related Experiment Video
Updated: May 22, 2025
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
Immunotherapy in Cervical Cancer: An Evolutionary Paradigm in Women's Reproductive Health
Mansi Damani1, Akshada Mhaske2, Sayali Dighe2
1Department of Pharmaceutics, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, University of Mumbai, Maharashtra, India.
Critical Reviews in Therapeutic Drug Carrier Systems
|March 14, 2025
Summary
Novel nano-immunotherapy strategies show promise for treating cervical cancer by enhancing immune response and overcoming limitations of traditional therapies. This approach combines nanotechnology with immunotherapy for improved treatment delivery and efficacy.
Area of Science:
- Oncology
- Nanotechnology
- Immunology
Background:
- Cervical cancer remains a significant global health issue, primarily caused by persistent human papillomavirus infection.
- Conventional treatments like chemotherapy, radiation, and surgery have limitations, necessitating innovative therapeutic strategies.
- Cancer immunotherapy shows potential but faces challenges due to the tumor's immunosuppressive microenvironment.
Purpose of the Study:
- To review the benefits of combining nanotechnology and immunotherapy for cervical cancer treatment.
- To highlight how nano-immunotherapy can overcome conventional treatment drawbacks and tumor-induced immunosuppression.
- To explore advancements and future directions in nano-immunotherapy for cervical cancer.
Main Methods:
- Review of current literature on nanotechnology applications in cancer immunotherapy.
- Analysis of various nanoplatforms (nanoparticles, micelles, liposomes, dendrimers) used in conjunction with immunotherapeutics.
- Discussion of strategies to mitigate safety concerns associated with nanoplatforms.
Main Results:
- The integration of nanotechnology with immunotherapy offers a promising approach to enhance treatment efficacy for cervical cancer.
- Nanoplatforms can be engineered to improve the delivery of immunotherapeutics and modulate the tumor microenvironment.
- Surface modification of nanoplatforms can address safety concerns like toxicity and inflammation.
Conclusions:
- Nano-immunotherapy represents a significant advancement in cervical cancer treatment, addressing limitations of conventional therapies.
- Further research and development in nano-immunotherapy hold potential for improved patient outcomes.
- Translational avenues for nano-immunotherapy in clinical settings are rapidly emerging.
Related Concept Videos
01:27Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
01:30Cancer Vaccines
319
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
319
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Cytotoxic T Cells-mediated Immune Response
823
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
823
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K